Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Stanley Lipschitz
Observed names:
Lipschitz, Stanley,
S Lipschitz,
S. Lipschitz
Observed institution:
University of Otago
OpenAlex ID:
A5113551060
Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis
2012
·
Steven Boonen
, Jean-Yves Reginster
, et al.
·
New England Journal of Medicine
·
366
PDF
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
2019
·
Michael R McClung
, Michelle L O'Donoghue
, et al.
·
The Lancet Diabetes & Endocrinology
·
175
Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial
2023
·
Bruno Dubois
, Jesús López-Arrieta
, et al.
·
Alzheimer s Research & Therapy
·
127
PDF
Subcutaneous Fluid Administration in Elderly Subjects: Validation of an Under‐Used Technique
1991
·
S. Lipschitz
, A. J. Campbell
, et al.
·
Journal of the American Geriatrics Society
·
89
Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer’s Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study
2016
·
Hana Florian
, Andreas Meier
, et al.
·
Journal of Alzheimer s Disease
·
38
Upper gastrointestinal and overall tolerability of alendronate once weekly in patients with osteoporosis: results of a randomized, double-blind, placebo-controlled study
2004
·
J. A. Eisman
, R. Rizzoli
, et al.
·
Current Medical Research and Opinion
·
38
Blood-brain and blood-lung barrier alteration by dysbaric exposure.
1977
·
C Chryssanthou
, M Springer
, et al.
·
PubMed
·
30
Modeling of Subcutaneous Absorption Kinetics of Infusion Solutions in the Elderly Using Technetium
1997
·
Michael S. Roberts
, Stanley Lipschitz
, et al.
·
Journal of Pharmacokinetics and Biopharmaceutics
·
18
Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial
2023
·
Bruno Dubois
, Jesús López‑Arrieta
, et al.
·
Alzheimer s Research & Therapy
·
11
PDF
Pharmacokinetics and bioavailability of Naprosyn CR 500 mg tablet, a new controlled-release formulation of naproxen, after single and multiple dosing
1991
·
Sompon Wanwimolruk
, Stanley Lipschitz
, et al.
·
International Journal of Pharmaceutics
·
4
New once-monthly osteoporosis treatment : osteoporosis
2015
·
Stanley Lipschitz
The Silver Surfers: Keeping the elderly healthy
2004
·
Stanley Lipschitz
·
CME/Continuing medical education
Evaluation of the relative bioavailability of 500 mg naprosyn (naproxen) controller-release tablets
1990
·
S. Wanwimolruk
, S. Lipschitz
, et al.
·
European Journal of Pharmacology
Show more works
View as search
Works count:
15
Citation count:
896
H-index:
9
I10-index:
9
Year
Topic
Type
